Donald Poon

1.0k total citations
14 papers, 774 citations indexed

About

Donald Poon is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Donald Poon has authored 14 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Epidemiology and 3 papers in Neurology. Recurrent topics in Donald Poon's work include Neuroendocrine Tumor Research Advances (4 papers), Frailty in Older Adults (3 papers) and Neuroblastoma Research and Treatments (3 papers). Donald Poon is often cited by papers focused on Neuroendocrine Tumor Research Advances (4 papers), Frailty in Older Adults (3 papers) and Neuroblastoma Research and Treatments (3 papers). Donald Poon collaborates with scholars based in Singapore, United States and Malaysia. Donald Poon's co-authors include Ravindran Kanesvaran, Huihua Li, Wan Cheng Chow, Khin Maung Win, Kōichi Tanaka, Wan Yee Lau, Harjit Singh, London Lucien Ooi, Eric Van Cutsem and Pierce K. H. Chow and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.

In The Last Decade

Donald Poon

14 papers receiving 759 citations

Peers

Donald Poon
Olumide B. Gbolahan United States
Carolyn Revta United States
Namrata Vijayvergia United States
Marianne Davies United States
K. Wakai Japan
Donald Poon
Citations per year, relative to Donald Poon Donald Poon (= 1×) peers Ángel Segura

Countries citing papers authored by Donald Poon

Since Specialization
Citations

This map shows the geographic impact of Donald Poon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald Poon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald Poon more than expected).

Fields of papers citing papers by Donald Poon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald Poon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald Poon. The network helps show where Donald Poon may publish in the future.

Co-authorship network of co-authors of Donald Poon

This figure shows the co-authorship network connecting the top 25 collaborators of Donald Poon. A scholar is included among the top collaborators of Donald Poon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald Poon. Donald Poon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Tan, Tira J., Whee Sze Ong, Tanujaa Rajasekaran, et al.. (2016). Identification of Comprehensive Geriatric Assessment Based Risk Factors for Malnutrition in Elderly Asian Cancer Patients. PLoS ONE. 11(5). e0156008–e0156008. 12 indexed citations
3.
Rajasekaran, Tanujaa, Tira J. Tan, Whee Sze Ong, et al.. (2016). Comprehensive Geriatric Assessment (CGA) based risk factors for increased caregiver burden among elderly Asian patients with cancer. Journal of Geriatric Oncology. 7(3). 211–218. 23 indexed citations
4.
Wolin, Edward M., Barbara Jarząb, Barbro Eriksson, et al.. (2015). Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues. Drug Design Development and Therapy. 9. 5075–5075. 150 indexed citations
5.
Wolin, Edward M., Barbara Jarząb, Barbro Eriksson, et al.. (2014). A Multicenter, Randomized, Blinded, Phase 3 Study of Pasireotide LAR vs Octreotide LAR in Patients with Metastatic Neuroendocrine Tumors (NET) with Disease-Related Symptoms Inadequately Controlled by Somatostatin Analogs. Pancreas. 43(3). 508–508. 2 indexed citations
8.
Farid, Mohamad, Whee Sze Ong, Mann Hong Tan, et al.. (2012). The Influence of Primary Site on Outcomes in Leiomyosarcoma. American Journal of Clinical Oncology. 36(4). 368–374. 32 indexed citations
9.
Extermann, Martine, William J. Fulp, Ji‐Hyun Lee, et al.. (2012). Quality of life of elderly patients undergoing concomitant chemoradiation therapy for head and neck cancers, including assessment of geriatric parameters.. Journal of Clinical Oncology. 30(15_suppl). 6100–6100. 1 indexed citations
10.
Kanesvaran, Ravindran, et al.. (2011). Analysis of Prognostic Factors of Comprehensive Geriatric Assessment and Development of a Clinical Scoring System in Elderly Asian Patients With Cancer. Journal of Clinical Oncology. 29(27). 3620–3627. 151 indexed citations
11.
Tai, David & Donald Poon. (2010). Molecular and Other Novel Advances in Treatment of Metastatic Epithelial and Medullary Thyroid Cancers. Journal of Oncology. 2010. 1–7. 6 indexed citations
12.
Huang, Jiaoti, et al.. (2009). A suspicious clot. Thorax. 64(11). 1011–1011. 2 indexed citations
13.
Poon, Donald, Benjamin O. Anderson, Li‐Tzong Chen, et al.. (2009). Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. The Lancet Oncology. 10(11). 1111–1118. 324 indexed citations
14.
Chan, H.S., et al.. (2005). Neuroimpairment, activity limitation, and participation restriction among children with cerebral palsy in Hong Kong.. PubMed. 11(5). 342–50. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026